Clinical Trials Logo

Anal Cancer Squamous Cell clinical trials

View clinical trials related to Anal Cancer Squamous Cell.

Filter by:
  • None
  • Page 1

NCT ID: NCT04462042 Recruiting - Clinical trials for Anal Cancer Squamous Cell

Proton Versus Photon Therapy in Anal Squamous Cell Carcinoma

SWANCA
Start date: April 7, 2021
Phase: N/A
Study type: Interventional

Dosimetric studies suggest that radiotherapy with protons has a potential to reduce side effects compared to treatment with photons for patients with anal carcinoma (AC). There are so far no studies comparing these treatment techniques in a randomised setting. The aim of this study is to compare side effects following photon therapy versus proton therapy within the framework of a randomised controlled trial.

NCT ID: NCT03870607 Recruiting - Clinical trials for Anal Cancer Squamous Cell

Prebiotics and Probiotics During Definitive Treatment With Chemotherapy-radiotherapy SCC of the Anal Canal (BISQUIT)

BISQUIT
Start date: March 13, 2019
Phase: Phase 2
Study type: Interventional

Phase II randomized study of the use of pre-and probiotics during the definitive treatment of chemotherapy-radiotherapy (Ch-RT) for patients with localized anal canal squamous cell cancer (ACSCC) with the objective of increasing the effectiveness of conventional treatment based on the assumptions of that there is a need for research that increases the cure rates of the definitive treatment of Ch-RT in the ACSCC; ACSCC is a virus-associated tumor in many cases and therefore potentially immunogenic; immunotherapy is a promising strategy in ACSCC; and that pre- and probiotics can stimulate the immune system through modulation of the intestinal microbiota, and improve oncological outcomes.